HOVE_SKIN_CLINIC_LIMITED - Accounts

Company Registration No. 07208565 (England and Wales)
HOVE SKIN CLINIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2021
PAGES FOR FILING WITH REGISTRAR
The Courtyard
Shoreham Road
Upper Beeding
Steyning
West Sussex
BN44 3TN
HOVE SKIN CLINIC LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 10
HOVE SKIN CLINIC LIMITED
COMPANY INFORMATION
- 1 -
Directors
Dr A D Morris
(Appointed 15 February 2021)
Mr S Cliff-Patel
Dr S Morris
(Appointed 15 February 2021)
Company number
07208565
Registered office
The Courtyard
Shoreham Road
Upper Beeding
Steyning
West Sussex
BN44 3TN
Accountants
TC Group
The Courtyard
Shoreham Road
Upper Beeding
Steyning
West Sussex
BN44 3TN
HOVE SKIN CLINIC LIMITED
BALANCE SHEET
AS AT
31 MARCH 2021
31 March 2021
- 2 -
2021
2020
as restated
Notes
£
£
£
£
Fixed assets
Intangible assets
3
-
0
53,333
Tangible assets
4
18,889
19,084
18,889
72,417
Current assets
Stocks
3,000
3,200
Debtors
5
536,729
563,994
Cash at bank and in hand
675,871
595,380
1,215,600
1,162,574
Creditors: amounts falling due within one year
6
(965,935)
(665,130)
Net current assets
249,665
497,444
Total assets less current liabilities
268,554
569,861
Provisions for liabilities
7
(1,809)
(825)
Net assets
266,745
569,036
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
266,645
568,936
Total equity
266,745
569,036
HOVE SKIN CLINIC LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2021
31 March 2021
- 3 -

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies and under section 479A of the Companies Act 2006 relating to subsidiary companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 28 March 2022 and are signed on its behalf by:
Dr A D Morris
Director
Company Registration No. 07208565
The notes on pages 4 to 10 form part of these financial statements
HOVE SKIN CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
- 4 -
1
Accounting policies
Company information

Hove Skin Clinic Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Courtyard, Shoreham Road, Upper Beeding, Steyning, West Sussex, BN44 3TN. The principal place of business is 13 New Church Road, Hove, East Sussex, BN3 4AA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Interest income is recognised when it is probable that the economic benefits will flow to the company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding and the effective interest rate applicable.

1.3
Intangible fixed assets - goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2010, has been amortised evenly over its estimated useful life of ten years.

 

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

HOVE SKIN CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 5 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% on reducing balance
Fixtures and fittings
25% on reducing balance
Computers
33% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

HOVE SKIN CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.11
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2021
2020
Number
Number
Total
-
0
-
0
HOVE SKIN CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 7 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2020 and 31 March 2021
3,200,000
Amortisation and impairment
At 1 April 2020
3,146,667
Amortisation charged for the year
53,333
At 31 March 2021
3,200,000
Carrying amount
At 31 March 2021
-
0
At 31 March 2020
53,333

The directors, having regard to the requirements of FRS102, have considered the current policy regarding amortisation of goodwill. They consider that the current policy has resulted in purchased goodwill being written off within ten years and therefore no change is necessary.

4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 April 2020
141,444
97,430
14,165
253,039
Additions
6,102
-
0
-
0
6,102
At 31 March 2021
147,546
97,430
14,165
259,141
Depreciation and impairment
At 1 April 2020
128,332
91,458
14,165
233,955
Depreciation charged in the year
4,804
1,493
-
0
6,297
At 31 March 2021
133,136
92,951
14,165
240,252
Carrying amount
At 31 March 2021
14,410
4,479
-
0
18,889
At 31 March 2020
13,112
5,972
-
0
19,084
HOVE SKIN CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 8 -
5
Debtors
2021
2020
Amounts falling due within one year:
£
£
Trade debtors
13,850
251,184
Amounts owed by group undertakings
338,181
307,010
Other debtors
184,698
5,800
536,729
563,994
6
Creditors: amounts falling due within one year
2021
2020
£
£
Trade creditors
272,289
1
Amounts owed to group undertakings
47,856
-
0
Corporation tax
2,896
186,140
Other creditors
642,894
478,989
965,935
665,130
7
Provisions for liabilities
2021
2020
£
£
Deferred tax liabilities
1,809
825
8
Called up share capital
2021
2020
2021
2020
Ordinary share capital
Number
Number
£
£
Authorised
Ordinary shares of £1 each
100
100
100
100
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
HOVE SKIN CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 9 -
9
Operating lease commitments
Lessee

Operating lease payments represent rentals payable by the company for its property. The lease is open ended and the company is required to give a minimum of 12 months notice. The rental is fixed at £47,000 per annum.

 

New lease agreements were signed on behalf of the Group by the parent company, Medical Clinics Limited, in November 2021.

10
Related party transactions

During the year the company entered into the following transactions with related parties:

A short term loan of £200,000 was extended to the company from shareholders of the parent company. At the balance sheet date £200,000 was outstanding (2020: £0).

 

11
Parent company

The parent company of Hove Skin Clinic Limited is Medical Clinics Limited and its registered office is:

The Courtyard

Shoreham Road,

Upper Beeding,

Steyning,

West Sussex,

England,

BN44 3TN

The company considers Medical Clinics Limited to exercise Ultimate Control

The smallest and largest undertaking for which the company is a member and for which group financial statements are prepared is Medical Clinics Limited.

12
Prior period adjustment
Changes to the balance sheet
As previously reported
Adjustment
As restated at 31 Mar 2020
£
£
£
Current assets
Debtors due within one year
896,022
(332,028)
563,994
Capital and reserves
Profit and loss
900,964
(332,028)
568,936
HOVE SKIN CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
12
Prior period adjustment
(Continued)
- 10 -
Changes to the profit and loss account
As previously reported
Adjustment
As restated
Period ended 31 March 2020
£
£
£
Turnover
4,933,800
(332,028)
4,601,772
Profit for the financial period
789,016
(332,028)
456,988
Reconciliation of changes in equity
1 April
31 March
2019
2020
Notes
£
£
Adjustments to prior year
Overstated income
1
-
(332,028)
Equity as previously reported
712,048
901,064
Equity as adjusted
712,048
569,036
Reconciliation of changes in profit for the previous financial period
2020
Notes
£
Adjustments to prior year
Overstated income
1
(332,028)
Profit as previously reported
789,016
Profit as adjusted
456,988
Notes to reconciliation
1 - Income

The accounts have been restated to incorporate the impact of overstated income and trade debtors. The change has resulted in reducing the profits available for distribution at 31 March 2020 after tax by £332,028.

2021-03-312020-04-01false31 March 2022CCH SoftwareCCH Accounts Production 2021.300No description of principal activityDr Andrew D MorrisMr Sandeep Cliff-PatelDr A D Morris072085652020-04-012021-03-3107208565bus:Director32020-04-012021-03-3107208565bus:Director42020-04-012021-03-3107208565bus:Director62020-04-012021-03-3107208565bus:Director12020-04-012021-03-3107208565bus:Director22020-04-012021-03-3107208565bus:RegisteredOffice2020-04-012021-03-31072085652021-03-3107208565core:NetGoodwill2021-03-3107208565core:NetGoodwill2020-03-31072085652019-04-012020-03-31072085652020-03-3107208565core:PlantMachinery2021-03-3107208565core:FurnitureFittings2021-03-3107208565core:ComputerEquipment2021-03-3107208565core:PlantMachinery2020-03-3107208565core:FurnitureFittings2020-03-3107208565core:ComputerEquipment2020-03-3107208565core:CurrentFinancialInstrumentscore:WithinOneYear2021-03-3107208565core:CurrentFinancialInstrumentscore:WithinOneYear2020-03-3107208565core:CurrentFinancialInstruments2021-03-3107208565core:CurrentFinancialInstruments2020-03-3107208565core:ShareCapital2021-03-3107208565core:ShareCapital2020-03-3107208565core:RetainedEarningsAccumulatedLosses2021-03-3107208565core:RetainedEarningsAccumulatedLosses2020-03-3107208565core:Goodwill2020-04-012021-03-3107208565core:PlantMachinery2020-04-012021-03-3107208565core:FurnitureFittings2020-04-012021-03-3107208565core:ComputerEquipment2020-04-012021-03-3107208565core:NetGoodwill2020-03-3107208565core:NetGoodwill2020-04-012021-03-3107208565core:PlantMachinery2020-03-3107208565core:FurnitureFittings2020-03-3107208565core:ComputerEquipment2020-03-31072085652020-03-3107208565core:WithinOneYear2021-03-3107208565core:WithinOneYear2020-03-3107208565core:ContinuingOperations2019-04-012020-03-3107208565bus:PrivateLimitedCompanyLtd2020-04-012021-03-3107208565bus:SmallCompaniesRegimeForAccounts2020-04-012021-03-3107208565bus:FRS1022020-04-012021-03-3107208565bus:AuditExempt-NoAccountantsReport2020-04-012021-03-3107208565bus:FullAccounts2020-04-012021-03-31xbrli:purexbrli:sharesiso4217:GBP